Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
Flavio Cadegiani, Carlos Gustavo Wambier, Andy Goren
Abstract
OPINION article Front. Med., 28 July 2020Sec. Pulmonary Medicine Volume 7 - 2020 | https://doi.org/10.3389/fmed.2020.00453
Topics & Concepts
ARDSCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Spironolactone2019-20 coronavirus outbreakAcute respiratory distressPandemicDrugCoronavirusIntensive care medicineVirologyAnesthesiaPharmacologyLungInternal medicineHeart failureOutbreakInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesCOVID-19 Impact on ReproductionStress Responses and Cortisol